PR View by Rob Rogers

Share this article:
Let's be clear. As one who has spent half a life working in the increasingly regulated “pay for what you get” advertising side of the communication business, I have regarded PR as something of an uncertain universe. The idea that a client could spend money on a communication service and only might receive media coverage was a notion I found confusing.

However, what has become clear is the important and expanding role PR can play in the transmission of healthcare information that is potentially problematic to promote through conventional channels. Elevating news of a new study whose findings may fall outside of the stringent guidelines of approved indication is a place where PR shines; and gaining awareness through media coverage is probably the surest way of getting this information to consumers and physicians.

Although there will always be a direct correlation between advertising claims and study results, the “grey gap” between what is supported for use in promotion and what has been found in a study has provided increasing scope for the use of PR as a highly effective communication tool. This opportunity may be further realized when one considers the results of a study* which found up to one-fifth of all prescriptions are prescribed for off-label uses.

An example of PR's effectiveness is found in the coverage of a 2008 study that implied Viagra was beneficial for the treatment of women suffering side effects from SSRIs. The widespread coverage of the study helped foster a positive dialogue, encouraging discussion about a debilitating side effect between women and physicians.

In an environment that is becoming more regulated whilst being more open to public scrutiny, PR holds an important and alluring promise.  All that said, I'm sold.

Rob Rogers is co-CEO of Sudler & Hennessey

*David C. Radley, MPH; Stan N. Finkelstein, MD; Randall S. Stafford, MD, PhD  Arch Intern Med. 2006;166:1021-1026. 

Share this article:

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"